haleon.com (HLN) Net Asset Value

Corporate company logo of Haleon (HLN)

Haleon plc (HLN) is a leading global player in the consumer healthcare segment, creating high-demand products for a wide range of customers. The company is currently scaling its international asset portfolio and reducing debt, with the indicator standing at 21.90. This price chart clearly demonstrates the stock's dynamics, as the business's success relies on brand recognition, seasonal demand, and access to pharmacy chains.

HLN Haleon Group Book Capitalization (04/28/2023 - 10/28/2026)

Financial and market metric breakdowns for Haleon (HLN)

- price and consensus price forecast:
Share Price Haleon Corp|HLN - Price Target Chart
- market capitalization data:
Market Valuation Haleon PLC|HLN - Enterprise Value
- book capitalization data:
Accounting Value of a Share Haleon|HLN - Book Capitalization|Market Capitalization to Book Value Ratio haleon.com|HLN - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Haleon plc|HLN - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Haleon PLC|HLN - Company Aggregate Debts|Debts to Book Capitalization Haleon PLC|HLN - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Haleon
Fundamental company valuation:Haleon plc
Flagship merchandise of Haleon Group

The book value of Haleon plc (HLN) represents the net value of assets minus all liabilities. This book value metric demonstrates the actual equity available for the development of Haleon plc (HLN) global brands. The trend of this metric reflects the financial stability of the over-the-counter market leader. Steady capital growth confirms the predictability of the business within the healthcare sector. A high level of net assets guarantees investment reliability with moderate returns.

Competitors of Haleon plc

KVUE: Accounting Capitalization|Company Book Value Verona Pharma plc (VRNA)|jyongbio.com (MENS) - Net Asset Value|LGND - Book Capitalization|Accounting Value of Company Amneal Pharmaceuticals, Inc.|Book Capitalization PRGO|Book Capitalization ALVO (Alvotech Biopharmaceuticals)|Company Book Value Liquidia Corporation|glpg.com - Accounting Value of Company|ANIP: Company Book Value|MNKD - Company Net Assets|AMPH: Book Capitalization|Book Capitalization Pacira Corp|SPRY - Company Net Assets|Accounting Value of Company TBPH|Aquestive Therapeutics, Inc. - Company Book Value|Total Stockholders' Equity scpharmaceuticals.com SCPH|Company Net Assets Tectonic Therapeutic (TECX)|Total Net Assets Tonix Pharmaceuticals Holding TNXP|Book Capitalization SXT China (SXTC)|EPRX - Accounting Value of Company|Book Capitalization BHST|EXOZ (Invizyne Technologies) - Total Stockholders' Equity|ORMP - Company Book Value|Accounting Value of Company Entera Bio Corp|MindWalk Holdings (HYFT) - Book Capitalization|Accounting Value of Company abvcpharma.com (ABVC)|Book Capitalization CPIX (Cumberland Pharmaceuticals Inc.)|Quantum BioPharma Ltd. - Book Capitalization|FGEN - Company Book Value|TELO - Company Book Value|Book Capitalization RANI|SNYR (Synergy CHC) - Total Stockholders' Equity|Company Book Value RLYB (Rallybio Corp)|Total Stockholders' Equity LEXX|Company Book Value Pulmatrix Corp PULM|Accounting Capitalization ftzy.com.cn PTHL|Company Net Assets Aptorum Group|lyratherapeutics.com - Accounting Value of Company|Company Book Value Impact BioMedical Inc|TNFA: Net Asset Value|cbdmd.com (YCBD) - Company Book Value|PainReform Corp (PRFX) - Company Book Value|Book Capitalization CYTO|Company Net Assets lipella.com|OptiNose (OPTN) - Book Capitalization|Accounting Value of Company PIRS (Pieris Pharmaceuticals Inc)|Company Book Value Procaps Group SA PROC|Petros Pharma - Company Book Value|Qilian International (QLI) - Company Book Value|SLRN: Accounting Capitalization|Company Book Value TFF Pharmaceuticals, Inc. (TFFP)